コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
2 tio 8.19, 95% CI 1.60-42.0, p = 0.01), fewer decompressive craniectomies (0% vs 25%, P = 0.02), less
3 p had an mRS score of 0-4 at 90 days without decompressive craniectomy (adjusted odds ratio 0.87, 95%
6 cohort, 129 of 148 patients (87%) underwent decompressive craniectomy (DC), and 17 of 148 (11%) unde
7 s (odds ratio, 1.7; p < 0.01), and following decompressive craniectomy (odds ratio, 1.8; p < 0.01) we
8 8 mmHg were associated with a lower risk for decompressive craniectomy (p = 0.042, aOR = 0.27), DCI o
13 outwards and equalizing pressure gradients, decompressive craniectomy appears to significantly reduc
15 e: delayed cerebral ischemia (DCI), need for decompressive craniectomy due to increased intracranial
19 such as hypertonic saline administration and decompressive craniectomy have solid foundations and can
22 ence highlighting the benefits and limits of decompressive craniectomy in malignant cerebral infarcti
31 intracranial pressure (>25 mm Hg) to undergo decompressive craniectomy or receive ongoing medical car
34 ter than or equal to 60 compared with the no decompressive craniectomy patients up to 10 years after
36 ed in 42 (41%) of 103 participants receiving decompressive craniectomy plus best medical treatment an
38 analysis, 36 (47%) of 77 participants in the decompressive craniectomy plus best medical treatment gr
39 The SWITCH trial aimed to assess whether decompressive craniectomy plus best medical treatment in
41 mus were randomly assigned to receive either decompressive craniectomy plus best medical treatment or
42 ed and 197 gave delayed informed consent (96 decompressive craniectomy plus best medical treatment, 1
46 ent model of post-traumatic brain injury and decompressive craniectomy that incorporates a biphasic,
47 tion to computed tomography in patients with decompressive craniectomy to assess the size of acute he
50 cal ventilation was required for 6.9-9 days, decompressive craniectomy was required for 6.25-29.3% of
52 ents were randomly assigned 1:1 to receive a decompressive craniectomy with standard care (surgical g
55 f Life after Brain Injury total score of 83 (decompressive craniectomy) versus 62 (no decompressive c
56 fe after Brain Injury total scores of 62 (no decompressive craniectomy) versus 79 (decompressive cran
57 groups, stage 3 treatments (barbiturates and decompressive craniectomy) were used if all stage 2 trea
59 reduce brain swelling, decrease the need for decompressive craniectomy, and improve clinical outcomes
60 ubdural hematoma who underwent craniotomy or decompressive craniectomy, disability and quality-of-lif
62 nnitol use, treatment with barbiturate coma, decompressive craniectomy, number of nonneurosurgical pr
63 ho suffered severe TBI and were subjected to decompressive craniectomy, we used NeuN, a neuronal mark
70 n 20 mm Hg, use of edema-directed therapies, decompressive craniotomy, or 3-month Glasgow Outcome Sca
73 o experienced maximum midline shift (MLS) or decompressive hemicraniectomy (DHC) in the acute (< 48 h
75 CT] infarct location, volume and outcomes in decompressive hemicraniectomy [DHC] for MMCA infarction.
76 rials have provided compelling evidence that decompressive hemicraniectomy for large hemispheric infa
78 Competing hazards regression identified age, decompressive hemicraniectomy, and intracranial infectio
79 variables collected during the acute phase: decompressive hemicraniectomy, intracerebral hemorrhage
80 nstrated a substantial survival benefit from decompressive hemicraniectomy, with a number needed to t
86 tic lumbar spinal stenosis to undergo either decompressive laminectomy alone (decompression-alone gro
88 graphic degenerative lumbar spinal stenosis, decompressive laminectomy improved symptoms more than no
89 oy rods) lumbar spinal fusion in addition to decompressive laminectomy in patients with symptomatic l
90 y decompressive laminectomy for stenosis and decompressive laminectomy with fusion for stenosis assoc
91 (IAP) is associated with ICP elevation, and decompressive laparotomy in patients with concurrent ele
92 inferior vena cava (IVC) treated by a portal decompressive procedure that bypassed the obstructed IVC
94 objectively evaluate the effect of timing of decompressive surgery for acute SCI on long-term neurolo
96 ical perfusion and CA in patients undergoing decompressive surgery for malignant hemispheric stroke.
97 ive intervention, and to clarify the role of decompressive surgery in older patients (>60 years old)
98 e did not improve functional recovery beyond decompressive surgery in patients with moderate-to-sever
100 tion/American Stroke Association guidelines, decompressive surgery is indicated in patients with cere
101 Trials indicate that for selected patients, decompressive surgery offers an advantage over nonoperat
104 elevant pathology consecutively referred for decompressive surgery to the National Hospital for Neuro
106 neoplastic or inflammatory myelopathies, and decompressive surgery was delayed by a median of 11 mont
107 s with acute thoracolumbar SCI who underwent decompressive surgery within five days of injury at part